Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: Application for the subcutaneous injection in rats

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 1-2, 2012, Pages 1-7

  Nishimura, Asako ^a   Hayakawa, Taro ^a,b   Yamamoto, Yu ^a   Hamori, Mami ^a   Tabata, Keiko ^a   Seto, Keiko ^a   Shibata, Nobuhito ^a  

^a DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^b OTSU MUNICIPAL HOSPITAL   (Japan)

Author keywords

Controlled release; Insulin; Nanofiber hydrogel; Pharmacodynamics; Pharmacokinetics; Subcutaneous injection

Indexed keywords

GLUCOSE; HUMAN INSULIN; ISOPHANE INSULIN; NANOFIBER; PIG INSULIN; SYNTHETIC INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HYDROGEL; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; WILD TYPE;

ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CATTLE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; HYDROGELS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; NANOFIBERS; OSMOLAR CONCENTRATION; PEPTIDES; PHASE TRANSITION; RATS; RATS, WISTAR; SOLUBILITY;

EID: 83655167083     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.10.013     Document Type: Article

References (28)

1. I.I. Abu-Hashim, T. Higashi, T. Anno, K. Motoyama, A.E. Abd-Eigawad, M.H. El-Shabouri, T.M. Borg, and H. Arima Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin Int. J. Pharm. 392 2010 83 91
2. A. Dornhorst, H.J. Luddeke, M. Honka, R.W. Ackermann, M. Meriläinen, B. Gallwitz, S. Sreenan Predictive Study Group Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the predictive study Curr. Med. Res. Opin. 24 2008 369 376 (Pubitemid 351294387)
3. J.L. Drury, and D.J. Mooney Hydrogels for tissue engineering. Scaffold design variables and applications Biomaterials 24 2003 4337 4351 (Pubitemid 36960132)
4. D.K. Dubey, and V. Tomar Role of molecular level interfacial forces in hard biomaterial mechanics: a review Ann. Biomed. Eng. 38 2010 2040 2055
5. J. Elisseeff Injectable cartilage tissue engineering Expert. Opin. Biol. Theor. 4 2004 1849 1859 (Pubitemid 39627137)
6. J.C. Garbern, A.S. Hoffman, and P.S. Stayton Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors Biomacromolecules 12 2010 1833 1839
7. L.A. Gurski, A.K. Jha, C. Zhang, X. Jia, and M.C. Farach-Carson Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells Biomaterials 31 2010 42 48
8. T. Hayakawa, M. Ishii, M. Watanabe, H. Iwase, A. Nishimura, T. Monden, K. Kamiuchi, M. Isono, and N. Shibata Replacement of neutral protamine Hagedorn insulin with the long-acting insulin analogue, detemir, improves glycemic control without weight gain in basal-bolus insulin therapy in Japanese patients with type 1 diabetes J. Diabetes Invest. 2 2011 71 77
9. T.C. Holmes, S. de Lacalle, X. Su, G. Lui, A. Rich, and S. Zhang Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds Proc. Natl. Acad. Sci. USA 97 2000 6728 6733 (Pubitemid 30412782)
10. Q. Hou, P.A. DeBank, and K.M. Shakesheff Injectable scaffolds for tissue regeneration J. Mater. Chem. 14 2004 1915 1923
11. D.P. Huynh, G.J. Im, S.Y. Chae, K.C. Lee, and D.S. Lee Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel J. Controlled Release 137 2009 20 24
12. M. Ishida, H. Sakai, S. Sugihara, S. Aoshima, S. Yokoyama, and M. Abe Controlled release of vitamin E from thermo-responsive polymeric physico-gel Chem. Pharm. Bull. 51 2003 1348 1349 (Pubitemid 41685603)
13. A. Jimenez-Kairuz, D. Allemandi, and R.H. Manzo Mechanism of lidocaine release from carbomer-lidocaine hydrogels J. Pharm. Sci. 91 2002 267 272 (Pubitemid 34074485)
14. J. Kisiday, M. Jim, B. Kurz, H. Hung, C. Semino, S. Zhang, and A.J. Grodzinsky Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair Proc. Natl. Acad. Sci. USA 99 2002 9996 10001 (Pubitemid 34831161)
15. S. Koutsopoulos, L.D. Unsworth, Y. Nagai, and S. Zhang Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold Proc. Natl. Acad. Sci. USA 24 2009 4623 4628
16. S. Kumar, J. Gope, A. Kumar, A. Parashar, C.M. Rauthan, and P.N. Dixit High pressure growth of nanocrystalline silicon films J. Nanosci. Nanotechnol. 8 2008 4211 4217
17. A.D. Maynard, D.B. Warheit, and M.A. Philbert The new toxicology of sophisticated materials: nanotoxicology and beyond Toxicol. Sci. 120 Suppl. 1 2011 S109 S129
18. A. Mesnukul, K. Yodkhum, and T. Phaechamud Solid dispersion matrix tablet comprising indomethacin-PEG-HPMC fabricated with fusion and mold technique Indian J. Pharm. Sci. 71 2009 413 420
19. Y. Nagai, L.D. Unsworth, S. Koutsopoulos, and S. Zhang Slow release of molecules in self-assembling peptide nanofiber scaffold J. Controlled Release 115 2006 18 25 (Pubitemid 44415076)
20. K. Nakamura, Y. Maitani, A.M. Lowman, K. Takayama, N.A. Peppas, and T. Nagai Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery J. Controlled Release 58 1996 329 335 (Pubitemid 29413027)
21. Y. Ogawa, M. Yamamoto, H. Okada, H. Yashiki, and T. Shimamoto Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer Chem. Pharm. Bull. 36 1988 1095 1103
22. M. Shichiri, H. Kishikawa, Y. Ohkubo, and N. Wake Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 2000 B21 B29 (Pubitemid 30185774)
23. C. Tang, X. Shao, B. Sun, W. Hung, and X. Zhao The effect of self-assembling peptide RADA 16-1 on the growth of human leukemia cells in vitro and in nude mice Int. J. Mol. Sci. 14 2009 2136 2145
24. The Diabetes Control and Complications Trial (DCTT) Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
25. The Diabetes Control and Complications Trial (DCTT) Research Group The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) Diabetologia 41 1998 416 423
26. The Diabetes Control and Complications Trial (DCTT) Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N. Engl. J. Med. 353 2005 2643 2653
27. T. Uchida, Y. Toida, S. Sakakibara, Y. Miyagawa, H. Tanaka, M. Nishikata, K. Tazuya, N. Yasuda, and K. Matsuyama Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers Chem. Pharm. Bull. 49 2001 1261 1266 (Pubitemid 33035633)
28. S. Zhang, T.C. Holmes, C.M. DiPersio, R.O. Hynes, X. Su, and A. Rich Self-complementary oligopeptide matrices support mammalian cell attachment Biomaterials 90 1995 3334 3338